Larissa Robinson
Primary Care · Jasper, ALNPI 1013282987
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 661 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 54 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. Among primary care clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 661 payments — averaging $16.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$933
- GSK$857
- Otsuka America Pharmaceutical, Inc.$634
- AstraZeneca$582
- Bayer$458
- plus $6K from 48 others
What the payments were for
- Food & beverage$10,66399%
- Education$851%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$10,747 in reported general payments places this provider in the 95th percentile of 159 primary care providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 121 | $78,058 |
| OzempicSemaglutide | 53 | $67,472 |
| EliquisApixaban | 65 | $58,281 |
| MounjaroTirzepatide | 23 | $44,529 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 29 | $34,048 |
| LinzessLinaclotide | 31 | $28,682 |
| MyrbetriqMirabegron | 25 | $22,749 |
| RybelsusSemaglutide | 15 | $21,205 |
| Breo ElliptaFluticasone/Vilanterol | 34 | $19,707 |
| JardianceEmpagliflozin | 15 | $16,740 |
| MovantikNaloxegol Oxalate | 17 | $12,627 |
| EntrestoSacubitril/Valsartan | 15 | $9,638 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 181 | $7,677 |
| SymbicortBudesonide/Formoterol Fumarate | 21 | $7,566 |
| Spiriva HandihalerTiotropium Bromide | 11 | $7,349 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $933 | $88,67768 claims |
| AstraZenecaFarxiga, Symbicort | $582 | $85,624142 claims |
| PfizerEliquis, Premarin | $387 | $60,70077 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $857 | $53,75563 claims |
| Lilly USA, LLCMounjaro | $352 | $44,52923 claims |
| AbbVieLinzess, Synthroid | $1,444 | $30,80964 claims |
| Astellas Pharma US IncMyrbetriq | $212 | $22,74925 claims |
| Boehringer IngelheimJardiance | $79 | $16,74015 claims |
| Redhill Biopharma Inc.Movantik | $56 | $12,62717 claims |
| NovartisEntresto | $126 | $9,63815 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $443 | $5,04211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 159 primary care providers in Alabama.
Other primary care in Jasper
- Keith MatthewsOpelika$20K
- Troy HendersonFultondale$18K
- April TateDothan$16K
- Brandy McGrawMobile$14K
- Cleo ValdezHuntsville$14K
- Jamie GhrigsbyMoulton$9K
- Josh WarrenBirmingham$9K
- Amber NelsonHoover$9K
- Valerie ZiemanFoley$8K
- Tammy CorneliusCullman$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.